{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:05:01Z","timestamp":1717200301087},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/mph.0000000000000231","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T13:23:49Z","timestamp":1407158629000},"page":"552-558","source":"Crossref","is-referenced-by-count":0,"title":["Malignant Melanoma in Teenagers and Young Adults"],"prefix":"10.1097","volume":"36","author":[{"given":"Nathalie A.","family":"Kolandijan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caimiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahit","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agop Y.","family":"Bedikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1200\/JCO.2005.02.899","article-title":". Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database.","volume":"23","author":"Strouse","year":"2005","journal-title":"J Clin Oncol"},{"key":"R2-8-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08880010290057327","article-title":". Cutaneous melanoma in childhood and adolescence.","volume":"19","author":"Hamre","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00042728-200802000-00003","article-title":"Trends in pediatric melanoma mortality in the United States, 1968 through 2004.","volume":"34","author":"Lewis","year":"2008","journal-title":"Dermatol Surg"},{"key":"R4-8-20210227","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/MPH.0b013e3181b91180","article-title":"A comparison of clinical trial enrollment between teenager and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.","volume":"31","author":"Downs-Canner","year":"2009","journal-title":"J Pediatric Hematol Oncol"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1054-139X(97)00110-9","article-title":". National cancer clinical trials: children have equal access; teenagers do not.","volume":"21","author":"Bleyer","year":"1997","journal-title":"J adolesc Health"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2008.09.011","article-title":"Childhood melanoma.","volume":"27","author":"Jen","year":"2009","journal-title":"Clinics in Dermatology"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1525-1470.2009.01078.x","article-title":". Melanoma and melanocytic tumors of uncertain malignant potential in children, teenagers and young adults-the Stanford experience 1995-2008.","volume":"27","author":"Berk","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1542\/peds.2004-0471","article-title":". Does melanoma behave differently in younger children than in adults A retrospective study of 33 cases of childhood melanoma from a single institution.","volume":"115","author":"Ferrari","year":"2005","journal-title":"Pediatrics"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1245\/s10434-009-0657-4","article-title":". Sentinel lymph node biopsy in pediatric and teenager cutaneous melanoma patients.","volume":"17","author":"Howman-Giles","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.mph.0000212973.28996.e4","article-title":". Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience.","volume":"28","author":"Shah","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1997.15.3.1039","article-title":". Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.","volume":"15","author":"Buzaid","year":"1997","journal-title":"J Clin Oncol"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimator from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion).","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Stat Soc B"},{"key":"R16-8-20210227","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00007611-197809000-00009","article-title":"Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and end results.","volume":"71","author":"Boddie","year":"1978","journal-title":"South Med J"},{"key":"R17-8-20210227","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/1097-0142(196605)19:5<620::AID-CNCR2820190504>3.0.CO;2-L","article-title":"Malignant melanoma in children.","volume":"19","author":"Skov-Jensen","year":"1966","journal-title":"Cancer"},{"key":"R18-8-20210227","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1542\/peds.55.2.191","article-title":"Metastatic malignant melanoma in pre-pubertal children.","volume":"55","author":"Trozak","year":"1975","journal-title":"Pediatrics"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":". Origin of familial malignant melanomas from heritable melanocytic lesions: the B-K mole syndrome.","volume":"114","author":"Clark","year":"1978","journal-title":"Arch Dermatol"},{"key":"R20-8-20210227","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2354.1997.00022.x","article-title":"A literature review of adolescence and cancer.","volume":"6","author":"Whyte","year":"1997","journal-title":"Eur J Cancer Care"},{"key":"R23-8-20210227","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cncr.22818","article-title":". Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.","volume":"110","author":"Livestro","year":"2007","journal-title":"Cancer"},{"key":"R24-8-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/pbc.20168","article-title":". High-risk surgically resected pediatric melanoma and adjuvant interferon therapy.","volume":"44","author":"Chao","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R25-8-20210227","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/1097-0142(19871015)60:8<1720::AID-CNCR2820600805>3.0.CO;2-H","article-title":"Adjuvant and neoadjuvant chemotherapy with dacarbazine in high-risk childhood melanoma.","volume":"60","author":"Boddie","year":"1987","journal-title":"Cancer"},{"key":"R26-8-20210227","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.2910500410","article-title":". Effective combination chemohormonal therapy for malignant melanoma: experience with three consecutive trials.","volume":"50","author":"McClay","year":"1992","journal-title":"Int J Cancer"},{"key":"R27-8-20210227","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/JCO.1991.9.8.1403","article-title":"Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.","volume":"9","author":"Falkson","year":"1991","journal-title":"J Clin Oncol"},{"key":"R28-8-20210227","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.1984.2.11.1229","article-title":"Malignant melanoma in childhood: clinical course and response to chemotherapy.","volume":"2","author":"Hayes","year":"1984","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:35:45Z","timestamp":1717191345000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201410000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000231","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}